CN Patent

CN107056786B — 阿卡替尼的制备方法

Assigned to Harbin Yida Pharmaceutical Ltd By Share Ltd · Expires 2019-05-07 · 7y expired

What this patent protects

本发明揭示了一种可用于白血病治疗的新药阿卡替尼(Acalabrutinib)的制备方法，其制备步骤包括：以3‑氯‑2‑甲醛基吡嗪为原料，经缩合、酰化、环合和胺化等反应制得阿卡替尼。本发明涉及的阿卡替尼(Acalabrutinib)的制备方法具有原料易得，工艺简洁，经济环保等优点，适合大规模工业化生产。

USPTO Abstract

本发明揭示了一种可用于白血病治疗的新药阿卡替尼(Acalabrutinib)的制备方法，其制备步骤包括：以3‑氯‑2‑甲醛基吡嗪为原料，经缩合、酰化、环合和胺化等反应制得阿卡替尼。本发明涉及的阿卡替尼(Acalabrutinib)的制备方法具有原料易得，工艺简洁，经济环保等优点，适合大规模工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN107056786B
Jurisdiction
CN
Classification
—
Expires
2019-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Harbin Yida Pharmaceutical Ltd By Share Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.